4//SEC Filing
Novartis Bioventures Ltd 4
Accession 0001104659-20-080559
CIK 0001722271other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:16 PM ET
Size
15.6 KB
Accession
0001104659-20-080559
Insider Transaction Report
Form 4
Akouos, Inc.AKUS
Novartis Bioventures Ltd
10% Owner
Transactions
- Conversion
Common Stock
2020-06-30+856,262→ 856,262 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2020-06-30−199,996→ 0 total(indirect: See Footnote)→ Common Stock (199,996 underlying) - Conversion
Common Stock
2020-06-30+199,996→ 1,056,258 total(indirect: See Footnote) - Purchase
Common Stock
2020-06-30$17.00/sh+125,000$2,125,000→ 1,181,258 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2020-06-30−856,262→ 0 total(indirect: See Footnote)→ Common Stock (856,262 underlying)
NOVARTIS AG
10% Owner
Transactions
- Conversion
Common Stock
2020-06-30+856,262→ 856,262 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2020-06-30−856,262→ 0 total(indirect: See Footnote)→ Common Stock (856,262 underlying) - Conversion
Common Stock
2020-06-30+199,996→ 1,056,258 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2020-06-30−199,996→ 0 total(indirect: See Footnote)→ Common Stock (199,996 underlying) - Purchase
Common Stock
2020-06-30$17.00/sh+125,000$2,125,000→ 1,181,258 total(indirect: See Footnote)
Footnotes (3)
- [F1]On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]Novartis Bioventures Ltd. is the record holder of the securities reported herein. As the indirect parent of Novartis Bioventures Ltd., Novartis AG may be deemed to share beneficial ownership of these securities.
- [F3]On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Documents
Issuer
Akouos, Inc.
CIK 0001722271
Entity typeother
IncorporatedBermuda
Related Parties
1- filerCIK 0001297709
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:16 PM ET
- Size
- 15.6 KB